News | November 22, 2025
AstraZeneca to invest $2 billion in Maryland manufacturing expansion
The multibillion-dollar Maryland expansion is part of AstraZeneca’s sweeping $50 billion global investment plan
The multibillion-dollar Maryland expansion is part of AstraZeneca’s sweeping $50 billion global investment plan
Repatha is now the first and only PCSK9 inhibitor to demonstrate significant reduction of cardiovascular events as both primary and secondary prevention
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
This strategic expansion marks a significant step in the company's global growth strategy
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
Expansion makes Merck Life Science in Bengaluru a key manufacturing location in the APAC region
Brenntag Specialties Pharma marks a strategic milestone with its first collaboration with a contract manufacturer to enhance its nutraceutical value chain
Construction of the plant will commence in 2025 with first production expected to be in 2027
Subscribe To Our Newsletter & Stay Updated
